Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.02 -0.05 (-2.42%)
At close: Oct 1, 2026 · 4:00 PM EDT

Polaryx Therapeutics (PLYX) Common Equity (2024 - 2026)

Updated

Polaryx Therapeutics (PLYX) recorded Common Equity of $10.94 million in Q2 2026, up 237.0% from $3.25 million a year earlier and up 339.7% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Common Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, Polaryx Therapeutics reported Common Equity of $4.57 million, down 3.1% from FY2024.

  • Across earlier years, Common Equity came in at $4.71 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 84.97 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.94 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 41.98 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 41.95 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.37 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 11.69 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 11.83 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 85.49 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 20.25 Bn
10 Polaryx Therapeutics 103.18 Mn 78.80 Mn - 10.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.94 Mn
Mar 31, 2026 2.49 Mn
Dec 31, 2025 4.57 Mn
Jun 30, 2025 3.25 Mn
Mar 31, 2025 4.25 Mn
Dec 31, 2024 4.71 Mn
API Access

Polaryx Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=PLYX&period=max&api_key=YOUR_API_KEY